In patients with type 2 diabetes and CKD, finerenone improved CV and kidney outcomes. (2022)

First Author: Mayne KJ
Attributed to:  Randomised trials in cardiovascular and metabolic disease funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.7326/j22-0029

PubMed Identifier: 35500259

Publication URI: http://europepmc.org/abstract/MED/35500259

Type: Journal Article/Review

Volume: 175

Parent Publication: Annals of internal medicine

Issue: 5

ISSN: 0003-4819